or Try an Advanced Search...

    Technical Analysis for NMRD - Nemaura Medical Inc.

    Grade Last Price % Change Price Change
    F 0.03 11.00% 0.00
    NMRD closed up 11.0 percent on Tuesday, May 7, 2024, on 3 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    Earnings due: May 29
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical NMRD trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 11.00%
    Volume Surge Other 11.00%
    New 52 Week Low Weakness 11.00%
    Wide Bands Range Expansion 11.00%
    Below Lower BB Weakness 11.00%
    Older End-of-Day Signals for NMRD ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 15 hours ago
    Gap Up Closed about 19 hours ago
    Gap Up Partially Closed about 19 hours ago
    Reversed from Up about 19 hours ago
    Gapped Up (Partial) about 19 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    NMRD Chart by TradingView
    Basic chart:

    Profile

    Nemaura Medical Inc. Description

    Nemaura Medical, Inc. is a holding company. The Company owns a diagnostic medical device company specializing in discovering, developing and commercializing specialty medical devices. The Company's focus is on the development of a continuous glucose monitoring (CGM) device, which consists of a disposable patch containing a sensor, and a non-disposable miniature electronic watch with a re-chargeable power source. CGM through a non-invasive patch can enable early detection of subtle changes in blood glucose levels. The Company, through its operating subsidiaries, performs medical device research and manufacturing of a CGM, named sugarBEAT. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes, and may also be used to screen pre-diabetic patients. The sugarBEAT device extracts analytes, such as glucose, to the surface of the skin in a non-invasive manner where it is measured using sensors and interpreted using an algorithm.

    Classification
    Sector: Healthcare
    Industry: Medical Devices
    Keywords: Medicine Diabetes Medical Device Glucose Endocrine System Blood Test Wireless Devices Diabetes Mellitus Medical Monitoring Blood Glucose Monitoring Endocrinology Type I Diabetes Blood Sugar Level Continuous Glucose Monitor Type II Diabetes

    Is NMRD a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jan 22 Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET
    Jan 10 Alzamend Neuro And 3 Other Stocks Under $3 Insiders Are Buying
    Jan 4 Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Jan 3 Important Update on Listing Status and Strategic Direction
    Dec 13 Nemaura Medical receives positive Nasdaq listing decision
    Dec 13 Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision
    Nov 21 Nemaura Medical secures $10M non-dilutive credit facility
    Nov 21 Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth
    Nov 17 Nemaura (NMRD) to Expand in UK With Metabolic Health Program
    Nov 16 Nemaura Medical First Half 2024 Earnings: US$0.13 loss per share (vs US$0.33 loss in 1H 2023)
    See more NMRD news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.25
    52 Week Low 0.0292
    Average Volume 31,184
    200-Day Moving Average 0.26
    50-Day Moving Average 0.07
    20-Day Moving Average 0.06
    10-Day Moving Average 0.05
    Average True Range 0.01
    RSI (14) 33.77
    ADX 30.11
    +DI 12.63
    -DI 24.70
    Chandelier Exit (Long, 3 ATRs) 0.06
    Chandelier Exit (Short, 3 ATRs) 0.07
    Upper Bollinger Bands 0.10
    Lower Bollinger Band 0.03
    Percent B (%b) 0.07
    BandWidth 110.09
    MACD Line -0.01
    MACD Signal Line -0.01
    MACD Histogram -0.0034
    Fundamentals Value
    Market Cap 962.35 Thousand
    Num Shares 28.9 Million
    EPS -0.39
    Price-to-Earnings (P/E) Ratio -0.09
    Price-to-Sales 766.31
    Price-to-Book 122.56
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.04
    Resistance 3 (R3) 0.04 0.04 0.04
    Resistance 2 (R2) 0.04 0.04 0.04 0.04
    Resistance 1 (R1) 0.04 0.03 0.03 0.04 0.04
    Pivot Point 0.03 0.03 0.03 0.03 0.03
    Support 1 (S1) 0.03 0.03 0.03 0.03 0.03
    Support 2 (S2) 0.03 0.03 0.03 0.03
    Support 3 (S3) 0.03 0.03 0.03
    Support 4 (S4) 0.03